HOTH Q4 2020 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOTHHoth Therapeutics, Inc.

$15M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$802,876

Net Income

-$756,787

EPS (Diluted)

$-1.53

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$657,276

Free Cash Flow

-$717,233

Stock-Based Comp.

$36,837

Balance Sheet

Total Assets

$5M

Total Liabilities

$597,149

Stockholders' Equity

$5M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$309	+100.0%
Operating Income	-$802,876	-$4M	+79.5%
Net Income	-$756,787	-$4M	+80.7%